Eyecyte-RPE trial involved 9 patients with geographic atrophy, using 3 ascending dose levels of hiPSC-derived RPE cells. No serious adverse events were reported, and patients showed an average vision ...

‘And so he started seeing fewer and fewer people. They allowed his faculties to atrophy. But I think, like knives, they have to be sharpened. They get sharpened by rubbing them up against stee ...

Geographic atrophy (GA) is a late stage of age-related ... In its early stages, GA typically affects the outer retina, involving the macula, but sparing the foveal region (Figure 2-1).

Geographic atrophy presents as a well-defined, round or oval area of hypopigmentation, indicating retinal pigment epithelium (RPE) and choriocapillaris atrophy. Several imaging techniques are used ...

Adverse events reported in ≥2% of patients treated with Vanrafia, and more frequently than placebo, include peripheral edema, anemia, and liver transaminase elevation. Vanrafia may cause serious birth ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated ...

With companies around the globe working to development new candidates for treating patients with retinal diseases ... is intended for the treatment of vision loss due to geographic atrophy (GA) ...